Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xiaoyi Wang & Hong Gao. (2020) Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 33:13, pages 2202-2208.
Read now
Read now
Jennifer Uzan, Marie Carbonnel, Olivier Piconne, Roland Asmar & Jean-Marc Ayoubi. (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular Health and Risk Management 7, pages 467-474.
Read now
Read now
Michael J. Kupferminc, Eli Rimon, Ariel Many, Maslovitz Sharon, Joseph B. Lessing & Ronni Gamzu. (2011) Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. The Journal of Maternal-Fetal & Neonatal Medicine 24:8, pages 1042-1045.
Read now
Read now
Articles from other publishers (45)
Christos-Georgios Kontovazainitis, Dimitra Gialamprinou, Georgios N. Katsaras, Abraham Pouliakis, Theodoros Theodoridis & Georgios Mitsiakos. (2022) Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis. American Journal of Perinatology 40:16, pages 1745-1764.
Crossref
Crossref
А. Є. Гусєва, М. Є. Кирильчук & В. І. Медведь. (2023) ПРОФІЛАКТИКА ПРЕЕКЛАМПСІЇ: СУЧАСНИЙ СТАН ПРОБЛЕМИ. Актуальні питання педіатрії, акушерства та гінекології:1, pages 53-64.
Crossref
Crossref
Li Zheng, Binbin Xia, Yuan Yuan, Yuran Wang & Yan Wang. (2022) Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Alessandra Bettiol, Laura Avagliano, Niccolò Lombardi, Giada Crescioli, Giacomo Emmi, Maria Letizia Urban, Gianni Virgili, Claudia Ravaldi & Alfredo Vannacci. (2021) Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta‐Analysis. Clinical Pharmacology & Therapeutics 110:1, pages 189-199.
Crossref
Crossref
John Allotey, Kym IE Snell, Melanie Smuk, Richard Hooper, Claire L Chan, Asif Ahmed, Lucy C Chappell, Peter von Dadelszen, Julie Dodds, Marcus Green, Louise Kenny, Asma Khalil, Khalid S Khan, Ben W Mol, Jenny Myers, Lucilla Poston, Basky Thilaganathan, Anne C Staff, Gordon CS Smith, Wessel Ganzevoort, Hannele Laivuori, Anthony O Odibo, Javier A Ramírez, John Kingdom, George Daskalakis, Diane Farrar, Ahmet A Baschat, Paul T Seed, Federico Prefumo, Fabricio da Silva Costa, Henk Groen, Francois Audibert, Jacques Masse, Ragnhild B Skråstad, Kjell Å Salvesen, Camilla Haavaldsen, Chie Nagata, Alice R Rumbold, Seppo Heinonen, Lisa M Askie, Luc JM Smits, Christina A Vinter, Per M Magnus, Kajantie Eero, Pia M Villa, Anne K Jenum, Louise B Andersen, Jane E Norman, Akihide Ohkuchi, Anne Eskild, Sohinee Bhattacharya, Fionnuala M McAuliffe, Alberto Galindo, Ignacio Herraiz, Lionel Carbillon, Kerstin Klipstein-Grobusch, SeonAe Yeo, Helena J Teede, Joyce L Browne, Karel GM Moons, Richard D Riley & Shakila Thangaratinam. (2020) Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis. Health Technology Assessment 24:72, pages 1-252.
Crossref
Crossref
Barry Jacobson, Virendra Rambiritch, Dara Paek, Tobias Sayre, Poobalan Naidoo, Jenny Shan & Rory Leisegang. (2019) Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Advances in Therapy 37:1, pages 27-40.
Crossref
Crossref
D.E. Lowry, D.J. Corsi, R.R. White, M. Guo, A. Lanes, G. Smith, M. Rodger, S.W. Wen, M. Walker & L. Gaudet. (2019) Association between prophylactic low‐molecular‐weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort. Journal of Thrombosis and Haemostasis 17:2, pages 345-349.
Crossref
Crossref
Kelsey McLaughlin, Ralph R. Scholten, John D. Parker, Enrico Ferrazzi & John C. P. Kingdom. (2018) Low molecular weight heparin for the prevention of severe preeclampsia: where next?. British Journal of Clinical Pharmacology 84:4, pages 673-678.
Crossref
Crossref
Sean K. Seeho, Charles S. Algert, Christine L. Roberts & Jane B. Ford. (2016) Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated. American Journal of Obstetrics and Gynecology 215:6, pages 785.e1-785.e8.
Crossref
Crossref
N. Sananes, A. Gaudineau, C.-Y. Akladios, L. Lecointre & B. Langer. (2016) Hipertensión arterial y embarazo. EMC - Ginecología-Obstetricia 52:2, pages 1-15.
Crossref
Crossref
Luigi Raio, Marc Baumann & Henning Schneider. 2016. Die Geburtshilfe. Die Geburtshilfe
449
494
.
Paula Alba & Munther Khamashta. 2016. Connective Tissue Disease. Connective Tissue Disease
147
158
.
Kelsey McLaughlinSascha DrewloJohn D. ParkerJohn C.P. Kingdom. (2015) Current Theories on the Prevention of Severe Preeclampsia With Low-Molecular Weight Heparin. Hypertension 66:6, pages 1098-1103.
Crossref
Crossref
Miriam F. van Oostwaard, Josje Langenveld, Ewoud Schuit, Dimitri N.M. Papatsonis, Mark A. Brown, Romano N. Byaruhanga, Sohinee Bhattacharya, Doris M. Campbell, Lucy C. Chappell, Francesca Chiaffarino, Isabella Crippa, Fabio Facchinetti, Sergio Ferrazzani, Enrico Ferrazzi, Ernesto A. Figueiró-Filho, Ingrid P.M. Gaugler-Senden, Camilla Haavaldsen, Jacob A. Lykke, Alfred K. Mbah, Vanessa M. Oliveira, Lucilla Poston, Christopher W.G. Redman, Raed Salim, Baskaran Thilaganathan, Patrizia Vergani, Jun Zhang, Eric A.P. Steegers, Ben Willem J. Mol & Wessel Ganzevoort. (2015) Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. American Journal of Obstetrics and Gynecology 212:5, pages 624.e1-624.e17.
Crossref
Crossref
Louise C. Kenny, Keith R. Mccrae & F.Gary Cunningham. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
379
396
.
Anne Cathrine Staff, Baha M. Sibai & F.Gary Cunningham. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
253
267
.
Luigi Raio, Marc Baumann & Henning Schneider. 2015. Die Geburtshilfe. Die Geburtshilfe
1
71
.
Marie Scully & Patrick O’Brien. 2015. Disorders of Thrombosis and Hemostasis in Pregnancy. Disorders of Thrombosis and Hemostasis in Pregnancy
295
313
.
Alessandro Ghidini. (2014) Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenatal Diagnosis 34:7, pages 649-654.
Crossref
Crossref
Rolf Becker, Thomas Keller, Holger Kiesewetter, Heiner Fangerau & Uta Bittner. (2013) Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. Archives of Gynecology and Obstetrics 288:1, pages 41-48.
Crossref
Crossref
Nazli Hossain & Michael J. Paidas. (2013) Inherited Thrombophilia. Clinics in Laboratory Medicine 33:2, pages 377-390.
Crossref
Crossref
Bálint Alasztics, Zoltán Kukor, Zita Pánczél & Sándor Valent. (2012) The pathophysiology of preeclampsia in view of the two-stage model. Orvosi Hetilap 153:30, pages 1167-1176.
Crossref
Crossref
Andrea Fodor, András Győrffy, Magdolna Váradi, Béla Fülesdi & Tamás Major. (2012) The possible options for the prevention of preeclampsia. Orvosi Hetilap 153:4, pages 144-151.
Crossref
Crossref
Silvia D’Ippolito, Amparo Santamaria Ortiz, Manuela Veglia, Chiara Tersigni & Nicoletta Di Simone. (2011) Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature. Reproductive Sciences 18:7, pages 602-613.
Crossref
Crossref
Michael Kupferminc, Eli Rimon, Ariel Many, Sharon Maslovitz, Joseph B Lessing & Ronni Gamzu. (2011) Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Blood Coagulation & Fibrinolysis 22:2, pages 123-126.
Crossref
Crossref
L. Raio, M. Baumann & H. Schneider. 2011. Die Geburtshilfe. Die Geburtshilfe
305
342
.
Belinda Jim, Shuchita Sharma, Tewabe Kebede & Anjali Acharya. (2010) Hypertension in Pregnancy. Cardiology in Review 18:4, pages 178-189.
Crossref
Crossref
O. Pourrat & F. Pierre. (2010) Pronostic obstétrical, rénal et vasculaire à long terme dans les suites de la prééclampsie. Annales Françaises d'Anesthésie et de Réanimation 29:5, pages e155-e160.
Crossref
Crossref
A.-S. Ducloy-Bouthors. (2010) Hémostase et prééclampsie. Annales Françaises d'Anesthésie et de Réanimation 29:5, pages e121-e134.
Crossref
Crossref
Fuat Emre Canpolat, Diclehan Orhan, Şule Yigit, Gülsev Kale, Murat Yurdakök & Gülsevin Tekinalp. (2012) The Effects of Antenatal Anticoagulants (Low-Molecular-Weight Heparin and Aspirin) on Neonatal Pulmonary Vasculature in Rabbits. Pediatric and Developmental Pathology 13:2, pages 107-111.
Crossref
Crossref
Yves Giguère, Marc Charland, Emmanuel Bujold, Nathalie Bernard, Sonya Grenier, François Rousseau, Julie Lafond, France Légaré & Jean-Claude Forest. (2010) Combining Biochemical and Ultrasonographic Markers in Predicting Preeclampsia: A Systematic Review. Clinical Chemistry 56:3, pages 361-375.
Crossref
Crossref
Jana Auer, Luc Camoin, François Guillonneau, Virginie Rigourd, Sonia T. Chelbi, Marjorie Leduc, Jérôme Laparre, Thérèse-Marie Mignot & Daniel Vaiman. (2010) Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. Journal of Proteomics 73:5, pages 1004-1017.
Crossref
Crossref
P. Deruelle, J.-M. Girard, N. Coutty & D. Subtil. (2010) Prévention de la prééclampsie. Annales Françaises d'Anesthésie et de Réanimation 29:3, pages e31-e35.
Crossref
Crossref
A. Mak, M. W.-L. Cheung, A. A.-c. Cheak & R. C.-m. Ho. (2009) Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology 49:2, pages 281-288.
Crossref
Crossref
Abeer EddibJohn Yeh. (2009) Prevention of Preeclampsia: Is it Still a Disappointment?. Clinical medicine. Women's health 2, pages CMWH.S2385.
Crossref
Crossref
E. REY, P. GARNEAU, M. DAVID, R. GAUTHIER, L. LEDUC, N. MICHON, F. MORIN, C. DEMERS, S.R. KAHN, L.A. MAGEE & M. RODGER. (2009) Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. Journal of Thrombosis and Haemostasis 7:1, pages 58-64.
Crossref
Crossref
O. Pourrat & F. Pierre. 2009. Prise en charge multidisciplinaire de la prééclampsie. Prise en charge multidisciplinaire de la prééclampsie
270
280
.
A.-S. Ducloy-Bouthors. 2009. Prise en charge multidisciplinaire de la prééclampsie. Prise en charge multidisciplinaire de la prééclampsie
205
236
.
P. Deruelle, J.-M. Girard, N. Coutty & D. Subtil. 2009. Prise en charge multidisciplinaire de la prééclampsie. Prise en charge multidisciplinaire de la prééclampsie
57
66
.
Louise Kenny, Philip N. Baker & F. Gary Cunningham. 2009. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
335
351
.
Baha M. Sibai & F. Gary Cunningham. 2009. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
213
225
.
F. Mecacci, B. Bianchi, A. Pieralli, B. Mangani, A. Moretti, R. Cioni, L. Giorgi, G. Mello & M. Matucci-Cerinic. (2008) Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies. Rheumatology 48:3, pages 246-249.
Crossref
Crossref
John R. Barton & Baha M. Sibai. (2008) Prediction and Prevention of Recurrent Preeclampsia. Obstetrics & Gynecology 112:2, pages 359-372.
Crossref
Crossref
Line Leduc, Emmanuelle Dubois, Larissa Takser, Evelyne Rey & Michèle David. (2007) Dalteparin and Low-Dose Aspirin in the Prevention of Adverse Obstetric Outcomes in Women With Inherited Thrombophilia. Journal of Obstetrics and Gynaecology Canada 29:10, pages 787-793.
Crossref
Crossref
Nazli Hossain & Michael J. Paidas. (2007) Adverse Pregnancy Outcome, the Uteroplacental Interface, and Preventive Strategies. Seminars in Perinatology 31:4, pages 208-212.
Crossref
Crossref